CLEC9A 抗体
(C-Type Lectin Domain Family 9, Member A (CLEC9A))
CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008 [PubMed 18408006]).[supplied by OMIM, Aug 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Recombinant CLEC9A 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant CLEC9A 抗体 (Biotin) | 人 | Human, 兔 Chimeric |
|
|
|
| CLEC9A 抗体 (AA 57-241) | 人 | 绵羊 Polyclonal |
|
|
|
| CLEC9A 抗体 (AA 57-241) (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (AA 57-264) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (AA 15-218) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Fluoro594) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (APC) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Fluoro488) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (PE) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Middle Region) (Fluoro647) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10B4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2a
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- APC
- 抗体亚型
- IgG2a
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- DMC469
- 标记
- Biotin
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 绵羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 57-241
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 12K62
- 标记
- APC
- 抗体亚型
- IgG1
- 抗原表位
- AA 57-241
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 11n48
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 57-264
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- Middle Region
Latest Publications for our CLEC9A 抗体
: "Defining human dendritic cell progenitors by multiparametric flow cytometry." in: Nature protocols, Vol. 10, Issue 9, pp. 1407-22, (2016) (PubMed).
: "Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates." in: European journal of immunology, Vol. 45, Issue 3, pp. 854-64, (2015) (PubMed).
: "Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 4, pp. 1622-35, (2014) (PubMed).
: "TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4697-708, (2014) (PubMed).
: "Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas." in: European journal of immunology, Vol. 44, Issue 7, pp. 1947-55, (2014) (PubMed).
: "Boosting antibody responses by targeting antigens to dendritic cells." in: Trends in immunology, Vol. 33, Issue 2, pp. 71-7, (2012) (PubMed).
: "Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A." in: European journal of immunology, Vol. 40, Issue 5, pp. 1255-65, (2010) (PubMed).
: "Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates." in: European journal of immunology, Vol. 45, Issue 3, pp. 854-64, (2015) (PubMed).
: "Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 4, pp. 1622-35, (2014) (PubMed).
: "TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4697-708, (2014) (PubMed).
: "Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas." in: European journal of immunology, Vol. 44, Issue 7, pp. 1947-55, (2014) (PubMed).
: "Boosting antibody responses by targeting antigens to dendritic cells." in: Trends in immunology, Vol. 33, Issue 2, pp. 71-7, (2012) (PubMed).
: "Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A." in: European journal of immunology, Vol. 40, Issue 5, pp. 1255-65, (2010) (PubMed).
Aliases for CLEC9A 抗体
C-type lectin domain family 9, member a (Clec9a) 抗体C-type lectin domain containing 9A (CLEC9A) 抗体
C-type lectin domain containing 9A (Clec9a) 抗体
C-type lectin domain family 9, member A (CLEC9A) 抗体
9830005G06Rik 抗体
DNGR-1 抗体
DNGR1 抗体
RGD1562513 抗体
UNQ9341 抗体
您还需要查找其他产品吗？
You are here:
